22 February 2000
US probes AstraZeneca spin-off
LIFE sciences giant AstraZeneca has been asked by the US federal trade
commission to provide more information about the spin-off of its
The £9.5 billion business is due to be merged with Swiss group Novartis agrochemicals division to create a new company, Syngenta.
Analysts believe regulators require the sale of seeds and crop protection
to overcome competitive concerns, reportsThe Guardian.
AstraZeneca still hopes to complete the deal by the second half of the
- Novartis and AstraZeneca to merge, FWi, 02 December, 1999
The Guardian 22/02/2000 page 27.